Literature DB >> 29383625

Genetic analysis of a novel missense mutation (Gly542Ser) with factor XII deficiency in a Chinese patient of consanguineous marriage.

Anqing Zou1, Mingshan Wang1, Yanhui Jin1, Xiaoli Cheng1, Kankan Su1, Lihong Yang2.   

Abstract

Coagulation factor XII deficiency is a rare autosomal recessive disorder, which could be found in a consanguineous family. We studied a Chinese family in which the activated partial thromboplastin time (APTT) of the proband had clearly prolonged up to 101.7 s, associated with low FXII activity of 3% and FXII antigen < 1%. To analyze the gene mutation in this FXII-deficient patient, we performed FXII mutation screening, and analyzed the DNA sequence of the F12 gene. A ClustalX-2.1-win and four online bioinformatics software services were used to study the conservatism and effects of the mutation. A transient in vitro expression study was performed to elucidate the possible pathological mechanism. Sequence analysis revealed a homozygous c.1681 G > A point mutation in exon 14, causing a novel Gly542Ser mutation in the catalytic domain. The results of the conservatism and bioinformatics analyses both indicated that the mutation likely affects the function of the protein. Additional expression studies in COS-7 cells showed that the antigen level of mutant FXII (FXII-Gly542Ser) was lower than wild type in culture medium, whereas the corresponding level of FXII antigen in cell lysates was equivalent. These results suggest that the Gly542Ser mutation causes FXII deficiency through intracellular degradation.

Entities:  

Keywords:  CRM; Expression study; Factor XII deficiency; Gene mutation; Genetic analysis

Mesh:

Year:  2018        PMID: 29383625     DOI: 10.1007/s12185-017-2393-z

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  1 in total

1.  Characterization of congenital factor XII deficiency in Taiwanese patients: identification of one novel and one common mutation.

Authors:  Sheng-Chieh Chou; Ching-Yeh Lin; Hsuan-Yu Lin; Chen-Hsueh Pai; Cheng-Ye Yu; Su-Feng Kuo; Jen-Shiou Lin; Po-Te Lin; Mei-Hua Hung; Han-Ni Hsieh; Hsiang-Chun Liu; Ming-Ching Shen
Journal:  Int J Hematol       Date:  2022-06-08       Impact factor: 2.319

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.